Clinical Trials Logo
  1. Home
  2. Hematology
  3. NCT04618848

Performance Evaluation Study

Hematology Clinical Trial

Official title:
Performance Evaluation Protocol for Sight Diagnostics' OLO CBC Analyzer by Ichilov Oncology Daily Care Center

Clinical Trial Summary

This study aims to establish OLO's performance accuracy of CBC results for finger prick samples across the OLO reportable range, and particularly around relevant medical decision points

Clinical Trial Description

This study aims to establish OLO's performance accuracy of CBC results for finger prick samples across the OLO reportable range, and particularly around relevant medical decision points. The evaluation will include two studies: 1. A matrix study will compare a capillary sample collected via finger prick with a venous sample collected into a blood tube, both scanned on OLO. 2. A method comparison study will compare Sight OLO to the site reference analyzer using a venous sample collected into a blood tube. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04618848
Study type Observational
Source Sight Diagnostics
Contact Yochay Eshel
Phone +972-52-8505747
Email yochay@sightdx.com
Status Not yet recruiting
Phase
Start date November 2020
Completion date December 2020
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05763186 - The Right Amount of Purge Useful for Blood Sampling on PiccLine (PiccLine) N/A
Completed NCT02835937 - Red Blood Cell Transfusion in the Ambulatory Setting: Impact on Home Functional Status N/A
Completed NCT01418846 - Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients N/A
Recruiting NCT04931329 - Onco-haematology Vigilance Card
Completed NCT03595501 - Analytical and Clinical Performance Testing Plan
Not yet recruiting NCT06007794 - Correlation Between Ultrasound-assessed Quadriceps Muscle Mass and Baseline Whole-body Densitometry Muscle Index in the Post-cancer Population (JUMP Research II) N/A
Recruiting NCT05242341 - Increase Understanding and Safety of Treatment N/A
Completed NCT01300026 - AMG 319 Lymphoid Malignancy FIH Phase 1
Completed NCT00066092 - Pegfilgrastim PBPC Mobilization Study Phase 2
Completed NCT00472290 - Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS) N/A